Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


2 Ann Surg Oncol
3 BMC Cancer
1 Br J Surg
1 Cancer
1 Cancer Lett
2 Clin Cancer Res
1 Curr Treat Options Oncol
2 Discov Oncol
1 Eur J Cancer
6 Gastrointest Endosc
1 Hum Pathol
1 Int J Cancer
1 Int J Colorectal Dis
1 Int J Oncol
3 J Surg Oncol
1 Oncogene
1 Oncology
1 PLoS Med
2 Proc Natl Acad Sci U S A

    Ann Surg Oncol

  1. KHAN MMM, Munir MM, Pawlik TM
    ASO Author Reflections: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
    Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15097.
    >> Share

  2. MEIER J, Murimwa G, Nehrubabu M, DiMartino L, et al
    ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis.
    Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15015.
    >> Share

    BMC Cancer

  3. SCHOCKEL L, Woischke C, Surendran SA, Michl M, et al
    PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
    BMC Cancer. 2024;24:234.
    >> Share

  4. WANG B, Ling D, Li L, Zhang J, et al
    Impact of preoperative white blood cell count on outcomes in different stage colorectal cancer patients undergoing surgical resection: a single-institution retrospective cohort study.
    BMC Cancer. 2024;24:242.
    >> Share

  5. JIN Y, Jiang A, Sun L, Lu Y, et al
    Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
    BMC Cancer. 2024;24:238.
    >> Share

    Br J Surg

  6. ALISEDA D, Arredondo J, Sanchez-Justicia C, Alvarellos A, et al
    Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Br J Surg. 2024;111:znae021.
    >> Share


  7. MAHAR AL, Biggs K, Hansford RL, Derksen S, et al
    Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population-based cross-sectional study.
    Cancer. 2023 Oct 30. doi: 10.1002/cncr.35068.
    >> Share

    Cancer Lett

  8. TAN R, Zhang Z, Ding P, Liu Y, et al
    A growth factor-reduced culture system for colorectal cancer organoids.
    Cancer Lett. 2024 Feb 19:216737. doi: 10.1016/j.canlet.2024.216737.
    >> Share

    Clin Cancer Res

  9. HEDAYAT S, Cascione L, Cunningham D, Schirripa M, et al
    Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer.
    Clin Cancer Res. 2024 Feb 20. doi: 10.1158/1078-0432.CCR-23-2748.
    >> Share

  10. ROMESSER PB, Capdevila J, Garcia-Carbonero R, Philip T, et al
    A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.
    Clin Cancer Res. 2024;30:695-702.
    >> Share

    Curr Treat Options Oncol

  11. VAN NASSAU SCMW, Bol GM, van der Baan FH, Roodhart JML, et al
    Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
    Curr Treat Options Oncol. 2024 Feb 17. doi: 10.1007/s11864-024-01186.
    >> Share

    Discov Oncol

  12. ZHANG Y, Dong L, Dai X, Huang Y, et al
    Modulation of intestinal metabolites by calorie restriction and its association with gut microbiota in a xenograft model of colorectal cancer.
    Discov Oncol. 2024;15:46.
    >> Share

  13. MANICKASAMY MK, Jayaprakash S, Girisa S, Kumar A, et al
    Delineating the role of nuclear receptors in colorectal cancer, a focused review.
    Discov Oncol. 2024;15:41.
    >> Share

    Eur J Cancer

  14. OSTERMAN E, Syriopoulou E, Martling A, Andersson TM, et al
    Corrigendum to "Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer" [Eur J Cancer 199 (2024) 113572].
    Eur J Cancer. 2024 Feb 20:113940. doi: 10.1016/j.ejca.2024.113940.
    >> Share

    Gastrointest Endosc

  15. LI B, Liu JY, He DL, Wan XJ, et al
    Validation and update of a clinical score model to predict technical difficulty of colorectal endoscopic submucosal dissection: a multicenter prospective cohort study.
    Gastrointest Endosc. 2024;99:387-397.
    >> Share

  16. LUI TKL, Ko MKL, Liu JJ, Xiao X, et al
    Artificial intelligence-assisted real-time monitoring of effective withdrawal time during colonoscopy: a novel quality marker of colonoscopy.
    Gastrointest Endosc. 2024;99:419-427.
    >> Share

  17. ALBOUYS J, Manzah I, Schaefer M, Legros R, et al
    Prevalence and clinical significance of the muscle retracting sign during endoscopic submucosal dissection of large macronodular colorectal lesions (with videos).
    Gastrointest Endosc. 2024;99:398-407.
    >> Share

    Endoscopic resection of T1 colorectal cancer with unfavorable histologic features: What shall we do next?
    Gastrointest Endosc. 2024;99:417-418.
    >> Share

  19. RADADIYA D, Desai M, Patel H, Srinivasan S, et al
    Analyzing methods for reducing recurrence rates after EMR of large nonpedunculated colorectal polyps: an indirect pairwise comparison.
    Gastrointest Endosc. 2024;99:326-336.
    >> Share

  20. MOHAN BP
    Artificial intelligence-aided colonoscopy in 10 years.
    Gastrointest Endosc. 2024;99:452-453.
    >> Share

    Hum Pathol

  21. JEPSEN DNM, Hoeg H, Bzorek M, Orhan A, et al
    Digitally assessed lymphocyte infiltration in rectal cancer biopsies is associated with pathological response to neoadjuvant therapy.
    Hum Pathol. 2024;144:61-70.
    >> Share

    Int J Cancer

  22. MENG C, Sun L, Shi J, Li Y, et al
    Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis.
    Int J Cancer. 2024 Feb 22. doi: 10.1002/ijc.34891.
    >> Share

    Int J Colorectal Dis

  23. AMMANN Y, Warschkow R, Schmied B, De Lorenzi D, et al
    Is survival after transanal total mesorectal excision (taTME) worse than that after traditional total mesorectal excision? A retrospective propensity score-adjusted cohort study.
    Int J Colorectal Dis. 2024;39:28.
    >> Share

    Int J Oncol

  24. WANG T, Li X, Ma R, Sun J, et al
    Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review).
    Int J Oncol. 2024;64:39.
    >> Share

    J Surg Oncol

  25. SHEN Y, Yang T, Huang L, Wang Z, et al
    Response to prediction of symptomatic anastomotic leak after rectal cancer surgery.
    J Surg Oncol. 2024;129:835-836.
    >> Share

  26. FILHO PRS, Bezerra TS, Marques TMDM, Nahime RH, et al
    An alternative robotic approach to precise colorectal transection and single-staple anastomosis in high anterior resection: Video correspondence.
    J Surg Oncol. 2024;129:802-803.
    >> Share

  27. SHEHATA MS, Lofftus SY, Park JY, Singh AS, et al
    Sarcoma in patients with Lynch syndrome and response to immunotherapy.
    J Surg Oncol. 2024;129:820-826.
    >> Share


  28. LI Y, Lauriola M, Kim D, Francesconi M, et al
    Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through beta-catenin pathway in colorectal cancer.
    Oncogene. 2024 Feb 20. doi: 10.1038/s41388-024-02979.
    >> Share


  29. NUMATA K, Shiozawa M, Ono Y, Iguchi K, et al
    Clinical significance of the post/preoperative anti-p53 antibody ratio in predicting the prognosis of patients with colorectal cancer after curative surgery and its usefulness in combination with carcinoembryonic antigen.
    Oncology. 2024 Feb 21. doi: 10.1159/000537963.
    >> Share

    PLoS Med

  30. DONG X, Du L, Luo Z, Xu Y, et al
    Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
    PLoS Med. 2024;21:e1004340.
    >> Share

    Proc Natl Acad Sci U S A

  31. JANSEN RA, Mainardi S, Dias MH, Bosma A, et al
    Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS-mutant cancers.
    Proc Natl Acad Sci U S A. 2024;121:e2319492121.
    >> Share

  32. XIE B, Zhang M, Li J, Cui J, et al
    KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2314128121.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016